Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Biochem Parasitol ; 70(1-2): 59-69, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7637715

RESUMO

Nucleoside transport may play a critical role in successful intracellular parasitism by Toxoplasma gondii. This protozoan is incapable of de novo purine synthesis, and must salvage purines from the host cell. We characterized purine transport by extracellular T. gondii tachyzoites, focusing on adenosine, the preferred salvage substrate. Although wild-type RH tachyzoites concentrated [3H]adenosine 1.8-fold within 30 s, approx. half of the [3H]adenosine was converted to nucleotide, consistent with the known high parasite adenosine kinase activity. Studies using an adenosine kinase deficient mutant confirmed that adenosine transport was non-concentrative. [14C]Inosine, [14C]hypoxanthine and [3H]adenine transport was also rapid and non-concentrative. Adenosine transport was inhibited by dipyridamole (IC50 approx. 0.7 microM), but not nitrobenzylthioinosine (15 microM). Transport of inosine, hypoxanthine and adenine was minimally inhibited by 10 microM dipyridamole, however. Competition experiments using unlabeled nucleosides and bases demonstrated distinct inhibitor profiles for [3H]adenosine and [14C]inosine transport. These results are most consistent with a single, dipyridamole-sensitive, adenosine transporter located in the T. gondii plasma membrane. Additional permeation pathways for inosine, hypoxanthine, adenine and other purines may also be present.


Assuntos
Adenosina/metabolismo , Proteínas de Transporte/metabolismo , Proteínas de Membrana/metabolismo , Proteínas de Protozoários/metabolismo , Toxoplasma/química , Adenosina Quinase/genética , Adenosina Quinase/metabolismo , Animais , Ligação Competitiva , Transporte Biológico , Proteínas de Transporte/efeitos dos fármacos , Dipiridamol/farmacologia , Proteínas de Membrana/efeitos dos fármacos , Proteínas de Transporte de Nucleosídeos , Proteínas de Protozoários/efeitos dos fármacos , Purinas/metabolismo , Tioinosina/análogos & derivados , Tioinosina/farmacologia , Toxoplasma/crescimento & desenvolvimento
2.
J Clin Invest ; 95(1): 367-76, 1995 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7814637

RESUMO

We investigated potential targets for the activity of protein synthesis inhibitors against the protozoan parasite Toxoplasma gondii. Although nanomolar concentrations of azithromycin and clindamycin prevent replication of T. gondii in both cell culture and in vivo assays, no inhibition of protein labeling was observed in either extracellular or intracellular parasites treated with up to 100 microM drug for up to 24 h. Quantitative analysis of > 300 individual spots on two-dimensional gels revealed no proteins selectively depleted by 100 microM azithromycin. In contrast, cycloheximide inhibited protein synthesis in a dose-dependent manner. Nucleotide sequence analysis of the peptidyl transferase region from genes encoding the large subunit of the parasite's ribosomal RNA predict that the cytoplasmic ribosomes of T. gondii, like other eukaryotic ribosomes, should be resistant to macrolide antibiotics. Combining cycloheximide treatment with two-dimensional gel analysis revealed a small subset of parasite proteins likely to be synthesized on mitochondrial ribosomes. Synthesis of these proteins was inhibited by 100 microM tetracycline, but not by 100 microM azithromycin or clindamycin. Ribosomal DNA sequences believed to be derived from the T. gondii mitochondrial genome predict macrolide/lincosamide resistance. PCR amplification of total T. gondii DNA identified an additional class of prokaryotic-type ribosomal genes, similar to the plastid-like ribosomal genes of the Plasmodium falciparum. Ribosomes encoded by these genes are predicted to be sensitive to the lincosamide/macrolide class of antibiotics, and may serve as the functional target for azithromycin, clindamycin, and other protein synthesis inhibitors in Toxoplasma and related parasites.


Assuntos
Citoplasma/efeitos dos fármacos , Macrolídeos , Organelas/efeitos dos fármacos , Inibidores da Síntese de Proteínas/farmacologia , Proteínas de Protozoários/biossíntese , Toxoplasma/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Azitromicina/farmacologia , Sequência de Bases , Clindamicina/farmacologia , Cicloeximida/farmacologia , DNA Mitocondrial , Eletroforese em Gel Bidimensional , Lincosamidas , Dados de Sequência Molecular , Plastídeos/genética , Homologia de Sequência do Ácido Nucleico , Tetraciclina/farmacologia
4.
Antimicrob Agents Chemother ; 38(7): 1620-7, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7979295

RESUMO

Agents effective against intracellular pathogens must enter infected cells, crossing vacuolar membranes surrounding the organisms and then penetrating into the microbe and localizing to the microbial target site. We have characterized these parameters for azithromycin entry into Toxoplasma gondii-infected Chinese hamster ovary cells and murine macrophage-like J774 cells. Azithromycin uptake into infected host cells was concentrative and was dependent upon proton gradients. Subcellular fractionation of azithromycin-loaded infected CHO cells demonstrated > 95% intracellular drug in host cell lysosomes and cytosol, with < 5% associated with the parasite. Uptake of azithromycin into the T. gondii vacuole increased if parasites were coated with antibody prior to internalization by murine J774 cells, conditions which result in the formation of acidified phagolysosomes. No redistribution or retention of azithromycin in the parasite was observed when drug efflux from antibiotic-loaded infected CHO cells was monitored. Azithromycin entry into extracellular T. gondii was concentrative, was temperature and pH dependent, and was not different when azithromycin-sensitive and -resistant parasites were compared. These results demonstrate that azithromycin concentrates primarily in acidified compartments in parasites and host cells. The high concentration of azithromycin within these compartments may not be biologically relevant to inhibition of intracellular parasite growth by this agent.


Assuntos
Azitromicina/metabolismo , Toxoplasma/fisiologia , Animais , Azitromicina/farmacocinética , Soluções Tampão , Células CHO , Linhagem Celular , Cricetinae , Cricetulus , Meia-Vida , Humanos , Indicadores e Reagentes , Camundongos , Organelas/metabolismo , Frações Subcelulares/metabolismo
5.
Proc Natl Acad Sci U S A ; 91(2): 509-13, 1994 Jan 18.
Artigo em Inglês | MEDLINE | ID: mdl-8290555

RESUMO

The obligate intracellular protozoan parasite Toxoplasma gondii creates and enters into a unique membrane-bounded cytoplasmic compartment, the parasitophorous vacuole, when invading mammalian host cells. By microinjecting polar fluorescent molecules into individual T. gondii-infected fibroblasts, we show here that the parasitophorous vacuole membrane (PVM) surrounding the parasite functions as a molecular sieve. Lucifer yellow (457 Da) displayed free bidirectional flux across the PVM and distinctly outlined the parasites, which did not take up the dye, within the vacuole. This dye movement was not appreciably delayed by pretreatment of cells with 5 mM probenecid or chilling the monolayer to 5 degrees C, suggesting that dye movement was due to passive permeation through a membrane pore rather than active transport. Calcein, fluo-3, and a series of fluorescein isothiocyanate-labeled peptides up to 1291 Da crossed the PVM in a size-restricted fashion. A labeled peptide of 1926 Da and labeled dextrans and proteins (> or = 3000 Da) failed to transit the PVM. This putative channel in the PVM therefore allows exchange of molecules up to 1300-1900 Da between the host cell cytoplasm and the parasitophorous vacuolar space.


Assuntos
Toxoplasma/fisiologia , Toxoplasmose/parasitologia , Vacúolos/parasitologia , Sequência de Aminoácidos , Animais , Transporte Biológico Ativo , Cálcio/metabolismo , Células Cultivadas , Citoplasma/parasitologia , Fibroblastos/metabolismo , Fibroblastos/parasitologia , Fluoresceína-5-Isotiocianato , Humanos , Membranas Intracelulares/metabolismo , Membranas Intracelulares/parasitologia , Membranas Intracelulares/ultraestrutura , Isoquinolinas , Microinjeções , Microscopia de Fluorescência , Sondas Moleculares , Dados de Sequência Molecular , Peptídeos/administração & dosagem , Peptídeos/química , Permeabilidade , Toxoplasmose/patologia , Vacúolos/metabolismo , Vacúolos/ultraestrutura
6.
J Leukoc Biol ; 51(5): 437-43, 1992 May.
Artigo em Inglês | MEDLINE | ID: mdl-1602237

RESUMO

The cytosolic concentration of free calcium ([Ca2+]i) plays an important role in the control of many neutrophil functions. In this study, we characterize the early rapid subcellular changes in [Ca2+]i that occur in adherent neutrophils during phagocytosis of zymosan particles, using both dual- and single-excitation wavelength Fura-2 ratio imaging. We observed a wave of elevated cytosolic calcium that began shortly after zymosan contact and propagated from the region of neutrophil contact with the zymosan throughout the cell at a rate of approximately 17 microns/s at 31 degrees C. The wave was initiated by both opsonized and unopsonized zymosan and occurred independently of extracellular calcium. Multiple characteristics of the [Ca2+]i signal (including the absolute and regional [Ca2+]i and wave properties such as amplitude, frequency, duration, and topography) may be responsible for the differential regulation of cellular functions in the neutrophil.


Assuntos
Cálcio/fisiologia , Neutrófilos/fisiologia , Fagocitose/fisiologia , Zimosan/imunologia , Cálcio/metabolismo , Citosol/metabolismo , Citosol/fisiologia , Humanos , Líquido Intracelular/metabolismo , Neutrófilos/metabolismo , Transdução de Sinais/fisiologia
7.
Infect Dis Clin North Am ; 3(3): 461-7, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2504811

RESUMO

Phagocytes may shelter intracellular pathogens from the otherwise lethal effects of many antibiotics. Research in conditions such as chronic granulomatous disease, tuberculosis, legionellosis, and experimental staphylococcal infection underscores the principle that an antibiotic must enter the cell in order to be active against an intracellular microorganism. Demonstrating entry does not guarantee activity, however. The microenvironment and intracellular distribution of the pathogen and antimicrobial agent, and interactions between agent, pathogen, and host cell all contribute to determining the treatment result.


Assuntos
Antibacterianos/farmacocinética , Permeabilidade da Membrana Celular , Animais , Antibacterianos/farmacologia , Humanos , Legionella/efeitos dos fármacos , Camundongos , Mycobacterium tuberculosis/efeitos dos fármacos , Fagócitos/metabolismo , Staphylococcus aureus/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA